PD‐1 and programmed death ligand 1 (PD‐L1) blockade rapidly precipitates diabetes development in the nonobese diabetic (NOD) mouse model of T1D and reversed diabetes protection in immunotherapy‐treated NOD mice.3, 4. Here, CD274 is linked to diabetes mellitus.